Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffrey J Pu
Jeffrey J Pu
University of Arizona
Medicine
Internal medicine
car t cells
anti complement
phase iii trials
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impacts of Total Body Irradiation in Allogeneic Umbilical Cord Blood Hematopoietic Stem Cell Transplantation
2021
Blood
Jeffrey J Pu
Kristin N. Berger
Hao Wang
Wei Fu
Elizabeth L Miller
Larisa Broglie
Heiko Konig
Frederick D. Goldman
Julie-An Talano
Sherif S. Farag
Melanie Comito
Show All
Source
Cite
Save
Citations (0)
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.
2021
Journal of Hematology & Oncology
Jing-Zhou Hou
Jing Christine Ye
Jeffrey J Pu
Hongtao Liu
Wei Ding
Hong Zheng
Delong Liu
Show All
Source
Cite
Save
Citations (3)
Two Currently Recruiting Randomized Phase III Trials: COMMODORE 1 and 2 Evaluating Crovalimab Vs Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Current Anti-Complement Therapy
2021
Blood
Austin G. Kulasekararaj
Antonio M. Risitano
Alexander Roeth
Guangsheng He
Jeffrey J Pu
Lilyan Wright
Anita Appius
Alexandre Sostelly
Sasha Sreckovic
Sven Stanzel
Talha Munir
Junichi Nishimura
Show All
Source
Cite
Save
Citations (0)
CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell Lymphoma.
2021
Cancer communications
Wenhai Deng
Panpan Chen
Wen Lei
Yang Xu
Nengwen Xu
Jeffrey J Pu
Aibin Liang
Wenbin Qian
Show All
Source
Cite
Save
Citations (0)
1